Papers
Topics
Authors
Recent
Search
2000 character limit reached

Confounder Detection via Treatment Intent

Updated 4 July 2026
  • The paper presents CDTI, a method that contrasts treated–untreated pairs to surface candidate hidden confounders by eliciting treatment intent.
  • It employs matching strategies such as Z-matching, Ï€-matching, and Z-dominance to suppress observed variables and emphasize unobserved treatment drivers.
  • Empirical studies in ICU EHR settings demonstrate plausible candidate confounders, highlighting the need for further validation in causal adjustment.

Searching arXiv for the specified paper and closely related work to ground the article in the current literature. arXiv search: "(Plecko et al., 26 May 2026) Confounder Detection via Treatment Intent" Confounder Detection via Treatment Intent (CDTI) is an observational study design for detecting candidate unobserved confounders by exploiting the fact that any hidden variable that affects treatment allocation must, in some form, have been available to the human decision-maker at decision time. The design constructs carefully matched treated–untreated pairs and then asks why treatment differed, with the goal of eliciting variables outside the recorded covariate set that explain the treatment contrast. CDTI is therefore not a causal estimator by itself. Its role is to surface candidate hidden treatment drivers that may later be measured, proxied, or incorporated into downstream adjustment procedures (Plecko et al., 26 May 2026).

1. Problem formulation and causal motivation

In the CDTI formulation, the treatment is XX, the outcome is YY, the observed covariates are ZZ, and the unobserved confounders are UU. The intended causal structure is

Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,

with possible dependence between ZZ and UU, represented by a bidirected relation. The observational analyst sees (Z,X,Y)(Z,X,Y), but not UU. When UU affects both treatment and outcome, adjustment on YY0 alone is insufficient, so the usual no-unobserved-confounding condition fails (Plecko et al., 26 May 2026).

The ICU example used to motivate CDTI makes this point concrete. Let YY1 be mechanical ventilation and YY2 be in-hospital mortality. Using observed EHR covariates YY3, the paper estimates the effect of treatment on the treated,

YY4

Across three ICU databases, the back-door-adjusted estimates suggest that mechanical ventilation increases mortality in the treated population. The paper interprets this as a near-certain empirical signature of unobserved confounding, because physicians ventilate patients for reasons that are only partly captured in structured EHR variables (Plecko et al., 26 May 2026).

This design addresses a specific failure mode of observational causal inference: the dataset does not contain all variables that guided treatment choice. Related hidden-confounding work makes the same identifiability obstacle explicit in simpler binary settings. In the three-node DAG YY5, YY6, YY7, the ATE is not identifiable from confounded observational data alone because many different full joint distributions YY8 induce the same observed YY9 while implying different causal effects (Gan et al., 2020). CDTI starts from the practical premise that, although ZZ0 is not recorded, a human decision-maker may still be able to articulate contrastive reasons for treatment differences (Plecko et al., 26 May 2026).

2. Matching design and stochastic dominance theory

CDTI does not ask experts abstractly which unmeasured variables might matter. It first constructs treated–untreated pairs ZZ1 such that ZZ2 and ZZ3, then queries why treatment differed. The core design choice is the matching strategy ZZ4, which suppresses obvious observed explanations in ZZ5 so that hidden explanations in ZZ6 become more salient (Plecko et al., 26 May 2026).

Strategy Pairing condition
ZZ7-matching ZZ8
ZZ9-matching UU0, where UU1
UU2-dominance UU3 coordinatewise
Marginal matching / random baseline Only UU4, UU5

The central theorem is stated in terms of multivariate stochastic order. Under appropriate assumptions UU6, for each strategy UU7,

UU8

UU9

Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,0

Here Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,1 denotes multivariate stochastic order: Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,2 for every coordinatewise non-decreasing Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,3 (Plecko et al., 26 May 2026).

For scalar Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,4, the sufficient condition for Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,5-matching is especially simple. If Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,6 and

Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,7

is non-decreasing in Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,8 for every Z→X,Z→Y,U→X,U→Y,X→Y,Z \to X,\quad Z \to Y,\quad U \to X,\quad U \to Y,\quad X \to Y,9, then

ZZ0

This is a monotone likelihood ratio argument: within a fixed ZZ1-stratum, treated units have larger posterior ZZ2 than untreated units when treatment probability increases with ZZ3 (Plecko et al., 26 May 2026).

For multivariate ZZ4, the conditions are stronger. The treatment mechanism must be non-decreasing in each coordinate of ZZ5, and ZZ6 must be log-supermodular: ZZ7 or, for twice-differentiable densities,

ZZ8

The log-supermodularity condition rules out strong tradeoffs among hidden severity axes; clinically, it encodes that hidden severities tend to cluster positively rather than offset one another (Plecko et al., 26 May 2026).

For ZZ9-dominance, the paper introduces

UU0

and requires cross-partial conditions: UU1

UU2

Under these plus the UU3-matching assumptions, if UU4, then

UU5

The paper interprets these inequalities as balancing a collider channel through conditioning on UU6 with a bidirected channel through marginal dependence between UU7 and UU8 (Plecko et al., 26 May 2026).

3. Expert elicitation, extraction, and success probabilities

The expert interaction is formalized as an extraction-and-selection process. Given a pair UU9 with (Z,X,Y)(Z,X,Y)0 and (Z,X,Y)(Z,X,Y)1, the expert produces a candidate set of explanations

(Z,X,Y)(Z,X,Y)2

where (Z,X,Y)(Z,X,Y)3 is the extraction strategy. Under perfect extraction (Z,X,Y)(Z,X,Y)4,

(Z,X,Y)(Z,X,Y)5

Thus, only variables on which the treated unit exceeds the untreated unit can explain the contrastive treatment decision (Plecko et al., 26 May 2026).

Selection is then modeled as choosing one explanation uniformly among candidates. If (Z,X,Y)(Z,X,Y)6 denotes the event that an unobserved variable is selected, then

(Z,X,Y)(Z,X,Y)7

Accuracy (Z,X,Y)(Z,X,Y)8 requires that the selected explanation is unobserved and genuinely satisfies the directional contrast (Z,X,Y)(Z,X,Y)9. Under perfect extraction,

UU0

where

UU1

The design objective is therefore explicit: maximize the number of hidden explanatory differences UU2 while minimizing the number of competing observed explanations UU3 (Plecko et al., 26 May 2026).

This leads to formal comparisons among strategies. Under perfect extraction, both UU4-matching and UU5-dominance have UU6, so success reduces to

UU7

The paper proves that

UU8

Hence, under the stated assumptions, dominance pairs are even better than exact UU9-matches (Plecko et al., 26 May 2026).

For UU0-matching versus random matching, the paper defines a surrogate utility

UU1

and marginal predictive strength

UU2

Under the UU3-matching conditions and continuity of each marginal UU4,

UU5

A stated implication is that if

UU6

then

UU7

This formalizes the intuition that balancing away observed variation is worthwhile when it removes more distracting UU8-signal than hidden UU9-signal (Plecko et al., 26 May 2026).

4. Empirical implementation in ICU and EHR settings

The paper’s proof of concept is built around ICU treatment effect estimation from EHR data, with mechanical ventilation as treatment and in-hospital mortality as outcome. In the semi-synthetic MIMIC-III setting, the 12 observed covariates are respiratory rate, mean arterial pressure (MAP), lactate, P/F ratio, YY00, YY01, oxygen saturation, age, sex, Charlson score, SOFA score, and admission-diagnosis indicators (Plecko et al., 26 May 2026).

Clinical notes are used as a proxy for physician knowledge. For the semi-synthetic environment, the paper extracts binary note-derived concept indicators using UMLS entity linking and negation detection implemented via SciSpaCy. The binary concepts used as latent confounders YY02 include pleural effusion, heart failure, dyspnea, pneumonia, pulmonary edema, Bloom syndrome, hypoxia, atrial fibrillation, hypertensive disease, and atelectasis, with YY03, all binary (Plecko et al., 26 May 2026).

The semi-synthetic construction starts with real MIMIC-III YY04 and text-derived YY05, then specifies treatment and outcome models: YY06 with YY07, and a logistic outcome model with YY08 for YY09 and direct treatment coefficient YY10, so treatment is truly protective. New YY11 are then sampled, while analysts observe only YY12 (Plecko et al., 26 May 2026).

The synthetic verification uses Gaussian YY13 with YY14 and logistic treatment

YY15

When the required assumptions hold, YY16-dominance outperforms YY17-matching as the dominance gap grows; when they fail, the advantage can reverse. For YY18-matching versus random matching, the paper varies

YY19

and reports that YY20-matching beats random matching for YY21, while the inequality reverses for YY22 (Plecko et al., 26 May 2026).

In the semi-synthetic MIMIC-III experiments, practical matching implementations are based on Euclidean distance on standardized YY23, coordinatewise dominance scores, estimated propensity differences, and random baselines. The main finding is an ordering of cumulative success rates: YY24-based strategies YY25-match and YY26-dominance are best, YY27-matching and YY28-dominance are next, and random matching is worst throughout. The paper also reports that mean success YY29 is highest for small propensity gaps and decreases monotonically as the gap widens (Plecko et al., 26 May 2026).

For real-data detection in MIMIC-III, the paper fits a BERT-based treatment predictor YY30 for YY31 using physiological covariates and text notes, and an xgboost model YY32 using only YY33, which is used to construct YY34-matched pairs. Using YY35-matching with YY36 selected pairs on a held-out set, and allowing each unit to appear at most three times, the paper performs ablation-based extraction. For each concept YY37, it removes mentions from the treated unit’s notes and defines concept impact as

YY38

Concepts with YY39 are kept as candidate confounders (Plecko et al., 26 May 2026).

The top 20 discovered concepts include pleural effusion, hemorrhage, pneumonia, dyspnea, hypoxia, pulmonary edema, pneumothorax, fever, tachycardia, and hypertensive disease. The paper groups them into pulmonary impairment/injury, infection/SIRS, hemorrhage/trauma, cardiac, and non-specific illness severity, and concludes that YY40 detected concepts are clinically highly plausible as confounders or confounder proxies for ventilation decisions (Plecko et al., 26 May 2026). However, when these discovered concepts are added to downstream adjustment sets, the ETT changes only slightly and the differences are not statistically significant. The stated explanation is that note-derived binary indicators are sparse and noisy proxies for the underlying latent confounders (Plecko et al., 26 May 2026).

5. Relation to adjacent deconfounding and confounder-selection frameworks

CDTI occupies a distinct position within a broader literature on hidden confounding, confounder selection, and treatment-assignment signals. Its closest relatives address neighboring problems rather than the same design objective.

"Selective deconfounding" in "Causal Inference With Selectively Deconfounded Data" (Gan et al., 2020) assumes a large observational dataset in which treatment and outcome are observed but one key confounder is missing, together with a smaller dataset in which that confounder is revealed. The contribution there is not confounder detection, but selective confounder measurement. The method reconstructs YY41 from known YY42 and estimated YY43, and shows that actively allocating the revealed-YY44 budget across observed YY45 strata can reduce sample complexity (Gan et al., 2020). This is methodologically close to selective measurement design, whereas CDTI is aimed at eliciting previously unrecorded treatment drivers (Plecko et al., 26 May 2026).

"Adversarial De-confounding in Individualised Treatment Effects Estimation" (Chauhan et al., 2022) uses treatment assignment as a proxy for treatment policy and learns disentangled latent representations YY46. A treatment classifier connected to YY47 through a gradient reversal layer encourages treatment-agnostic balanced confounder representations for ITE estimation (Chauhan et al., 2022). That approach uses treatment-assignment signals to shape latent space, but it does not provide explicit variable-level confounder detection or expert-elicited treatment-intent explanations. CDTI, by contrast, is explicitly contrastive and pair-based (Plecko et al., 26 May 2026).

"ConfoundingSHAP: Quantifying confounding strength in causal inference" (Brockschmidt et al., 11 May 2026) targets a different detection problem: which observed covariates act as confounders. It defines residual confounding bias under restricted adjustment,

YY48

and constructs Shapley values over adjustment-set coalitions to quantify how much each observed covariate reduces residual bias relative to the full observed set (Brockschmidt et al., 11 May 2026). This distinguishes confounders from instruments or prognostic variables among measured covariates. CDTI instead seeks candidate unobserved confounders that are absent from the original YY49 (Plecko et al., 26 May 2026).

"Confounder selection via iterative graph expansion" (Guo et al., 2023) addresses confounder selection through causal-graphical elicitation. Starting from YY50, it queries the user for primary adjustment sets and incrementally expands a working ADMG until a sufficient adjustment set is found or ruled out. The method is sound and complete if the user correctly specifies the primary adjustment sets at every step (Guo et al., 2023). This is interactive and expert-driven like CDTI, but the elicited object is structural graph information rather than contrastive treatment intent. A plausible implication is that CDTI could provide candidate variables that later enter a graphical confounder-selection workflow.

"Inferring the Effect of a Confounded Treatment by Calibrating Resistant Population's Variance" (Qin et al., 2023) is relevant at the level of hidden treatment-selection bias rather than confounder discovery. It identifies the conditional average treatment effect on the treated as one of two possible values under nondeterministic treatment assignment, equality of conditional variances of the two potential outcomes in the treatment group, and a resistant population that calibrates YY51 (Qin et al., 2023). This quantifies the magnitude of hidden bias caused by latent treatment selection, but it does not detect the underlying confounder or infer treatment intent directly.

6. Interpretation, misconceptions, and limitations

CDTI is best understood as a study design for generating candidate hidden confounders, not as a proof that a detected concept is a true confounder of YY52. The paper states explicitly that detecting a candidate hidden treatment driver does not certify that it is a genuine confounder, nor that adding it restores back-door admissibility (Plecko et al., 26 May 2026). This distinguishes CDTI from methods that assume the confounder is already known and merely expensive to measure (Gan et al., 2020).

A second common misconception is to equate treatment intent with any variable predictive of treatment. Related work on observed-covariate confounding makes clear that variables associated only with treatment assignment may instead be instruments, while variables associated only with outcomes are prognostic covariates (Brockschmidt et al., 11 May 2026). CDTI avoids making that identification from treatment prediction alone; it elicits candidate variables because they explain treatment disagreement after observed explanations have been neutralized (Plecko et al., 26 May 2026).

The paper gives explicit conditions under which CDTI can succeed: hidden variables YY53 affect treatment monotonically, hidden dimensions are positively associated at fixed YY54, matching suppresses observed explanations YY55, the expert can articulate contrastive reasons for treatment differences, and elicited concepts are measured or proxied with enough fidelity to be useful later (Plecko et al., 26 May 2026). It can fail when treatment depends on tacit, subconscious, or inarticulable cues; when YY56 coordinates trade off rather than co-cluster; when YY57 and YY58 are too strongly correlated; when matching leaves many observed competing explanations; when extracted variables are noisy or post-treatment; or when the elicited concept is plausible but not actually a confounder of YY59 (Plecko et al., 26 May 2026).

Practical limitations are substantial. The method imposes expert burden through repeated pairwise comparisons. Elicited explanations may be vague, high-level, or inconsistent. Measurement error is central: in the ICU application, clinically plausible concepts were detected, but downstream bias reduction remained limited because note-derived binary indicators were sparse and noisy proxies. Any elicited variable used in causal analysis must also be verified as pre-treatment; in note-based settings, timestamps and retrospective documentation matter (Plecko et al., 26 May 2026).

Within the broader causal-inference landscape, CDTI therefore fills a narrow but important role. It is not a replacement for randomized trials, front-door or IV identification, sensitivity analysis, or graphical adjustment criteria. It is a procedure for surfacing what the dataset failed to record by querying differential treatment decisions in carefully selected pairs (Plecko et al., 26 May 2026). This suggests a natural downstream workflow: use CDTI to propose candidate hidden confounders or proxies, then assess those variables within standard adjustment, representation-learning, Shapley attribution, or causal-graphical selection pipelines (Brockschmidt et al., 11 May 2026).

Topic to Video (Beta)

No one has generated a video about this topic yet.

Whiteboard

No one has generated a whiteboard explanation for this topic yet.

Follow Topic

Get notified by email when new papers are published related to Confounder Detection via Treatment Intent.